Patent · US Active

Compounds and compositions for inhibition of FASN

US10800750B2 · kind B2 · utility

0Cited by

56References

20Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

Kenneth W. Bair · Chapel Hill, US
David R. Lancia, Jr. · Boston, US
Hongbin Li · Newtown, US
James Loch · Watertown, US
Wei Lu · Newton, US
Matthew W. Martin · Arlington, US
David S. Millan · Watertown, US
Shawn Schiller · Haverhill, US
Mark J. Tebbe · Hamburg, DE

Key dates

Filing date	Sep 10, 2019
Grant date	Oct 13, 2020
Priority date	—
Expiry date	Sep 19, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.